The Melbourne Brain Genome Project has been launched, thanks
to a grant from the NHMRC.
The project will study gene expression in normal mice and specific mouse
models that mimic human diseases including Down syndrome, Alzheimer's
disease and Parkinson's disease .
One of the major impacts of the human and mouse genome projects will
be in understanding the function of the brain. Our brains make us what
we are, both as individuals and as a species and displays breathtaking
sophistication of function, Studying the genetic make-up of the human
brain may provide a plethora of information that will have tremendous
ramifications in understanding brain development and function. But more
importantly, such knowledge will provide valuable insights into the
nervous system, how it works, why the system sometimes fails, and how
to treat it.
Using SAGE and microarray technology, the Melbourne Brain Genome Project
will scan expressed genes from different brains. Global "snap-shots"
of gene patterns will have diagnostic and prognostic value and eventually
lead to identification of potential targets for therapeutic interventions
in neurological diseases as well as advance our knowledge of normal
brain function. The project will also provide a systematic comparison
of gene expression technologies, determine the validity of mouse global
gene expression studies for extrapolation to humans and make all data
publicly available to the Australian Research Community.
The NHMRC recently
launched its Program in Medical Genomics. There were 63 expressions
of interest (EOIs). 23 short listed EOIs were sent to NIH nominated
scientists in the USA for ranking. Based on these rankings,12 full applications
were invited. 4 applications have been funded. This includes a team
of Melbourne scientists granted ~$4m AUD over 5 years for their application:
Large scale analysis of mouse nervous system development and disease
using SAGE and microarrays. This is a unique collaboration bringing
together genetic and neuroscience specialists, Dr Hamish S. Scott (Genetics
and Bioinformatics Division) of the Walter and Eliza Hall Institute;
Associate Prof Seong-Seng Tan (Brain Development Group) of the Howard
Florey Institute; and Prof Colin Masters of the Department of Pathology
at the University of Melbourne.